Skip to main content

GOLDMAN SACHS GROUP INC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in SYRE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,615,671
+$4,604,542 QoQ
Shares Held
269,938
-1.9% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. SYRE ranks #123 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,615,671 269,938
2025-12-31 $9,011,129 275,065
2025-09-30 $5,522,972 329,533
2025-06-30 $7,835,537 523,416
2025-03-31 $3,179,691 197,068
2024-12-31 $17,403,010 747,552
2024-09-30 $4,979,524 169,314
2024-06-30 $20,996,381 893,083
2024-03-31 $9,099,975 239,915